Executive Committee

The Executive Committee provides overall leadership and guidance to the Consortium through regular meetings and ongoing oversight of Consortium activities.

The Executive Committee consists of an Executive Chair, Scientific Chair, and Clinical Chair, together with a representative from the Genetic Aortic Disorders Association (GADA) Canada Board. Members leading the data coordinating centres for MAC are also appointed to the Executive Committee.

The Executive 
committee will:

  • Seek input from members to define the Consortium’s goals, priorities, and strategic objectives.
  • Work with partners and stakeholders to support the long-term sustainability of the Consortium.
  • Establish and maintain standards, policies, and procedures that support Consortium activities.
  • Promote the dissemination of research findings, resources, and knowledge to the research and clinical communities.
  • Foster collaboration, alignment, and engagement among participating centres in support of the Consortium’s shared vision and objectives.
  • Ensure fair, transparent, and equitable decision-making while considering the needs and perspectives of participating members.
  • Serve as the principal decision-making body for strategic, organizational, legal, technical, financial, operational, and personnel matters.

The Executive Chair provides direct leadership for all governance, administrative, legislative, and ethical activities and implements these activities.  In addition, the Executive chair acts as the leader for overall coordination of activities, meetings and agendas.

The Past Executive Chair provides expertise and guidance for overall activities of the consortium. A majority vote from the members of the Executive Committee will decide the appointment of the new Executive Chair and direct the current Chair to the Past Executive Chair position. The Past Executive Chair must serve a minimum of 3 years as the Executive Chair. There can be more than one Past Executive Chair for the MAC. The most recent Past Executive Chair will serve on the Executive Committee.

The Scientific/Research Chair provides direct leadership and guidance for all research and scientific activities.

The Clinical Chair provides direct leadership and guidance for all activities related to collection of phenotype data.

The GADA Canada will function as Administrative support to the Executive Committee and the Consortium members. A Director from the GADA Canada Board will serve on the Executive Committee.